The Significances of Serum CA19-9, CA125, CEA, CYFRA21-1, CA15-3 and Galectin-3 in the Differential Diagnosis of Pancreatic Lesion

doi:10.11748/bjmy.issn.1006-1703.2019.05.011

PDF(3748 KB)

Labeled Immunoassays and Clinical Medicine ›› 2019, Vol. 26 ›› Issue (5) : 763-767. DOI: 10.11748/bjmy.issn.1006-1703.2019.05.011

The Significances of Serum CA19-9, CA125, CEA, CYFRA21-1, CA15-3 and Galectin-3 in the Differential Diagnosis of Pancreatic Lesion

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 26(5): 763-767 https://doi.org/10.11748/bjmy.issn.1006-1703.2019.05.011

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(3748 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2018-09-29	2019-02-19	2019-05-25
Issue Date
2019-06-01

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS